Tue, August 15, 2023

Graig Suvannavejh Downgraded (BTAI) to Hold and Decreased Target to $4 on, Aug 15th, 2023

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -and-decreased-target-to-4-on-aug-15th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Graig Suvannavejh of Mizuho, Downgraded "BioXcel Therapeutics, Inc." (BTAI) to Hold and Decreased Target from $40 to $4 on, Aug 15th, 2023.

Graig has made no other calls on BTAI in the last 4 months.



There are 2 other peers that have a rating on BTAI. Out of the 2 peers that are also analyzing BTAI, 1 agrees with Graig's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Yatin Suneja of "Guggenheim" Downgraded from Strong Buy to Hold on, Monday, July 17th, 2023


This is the rating of the analyst that currently disagrees with Graig


  • Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $60 on, Monday, July 3rd, 2023